期刊文献+

110℃碘化油-顺铂混悬剂超选择肝动脉化疗栓塞治疗中晚期肝癌术后不良反应及对患者生存期的影响

The study of complications and existent term of 110℃DDP-lipiodol via Intra-arterial Thermochemotherapy in Terminal Hepatic Carcinoma
下载PDF
导出
摘要 目的:观察110℃碘化油-顺铂混悬剂超选择肝动脉化疗栓塞治疗中晚期肝癌术后患者的临床不良反应的发生情况及该种治疗方法对患者生存期的影响。方法:跟踪随访对照组和实验组患者术后不良反应发生的情况及生存期的长短,进行回顾性对照分析。结果:实验组栓塞术后的发热、恶心、肝功能损害等不良反应程度较对照组略重,但差异无统计学意义,未发生特殊或严重的术后并发症及副反应。实验组的患者生存期较对照组延长,差异有统计学意义。结论:110℃碘化油-顺铂混悬剂超选择肝动脉化疗栓塞治疗中晚期肝癌能有效延长患者生存期,而无严重的不良反应及并发症,是一种利大于弊的有效治疗中晚期肝癌的介入治疗方法。 Objective :To observe the acomplications and existent term of 110℃ DDP-lipiodol via intra-arterial thermochemotherapy in terminal hepatic carcinoma. Methods:sixty patients with advanced hepatic carcinoma were divided into study group and control group. Intra-hepatic-arterial chemoembolization was performed in all patients. For patients in study group the solution was warmed up to 110℃ ,while the patients in control group the temperature of solution was normal. Observation on the acomplications and existent term after the therapy was made. Results:The symptoms of study group, such as fever,queasiness,damage of hepatic function is slightly heavier than control group. But it is no statistical meaning. There are no difference in bad reaction and complication of the therapy. The eXistent term of study group is longer than control group. Conclusion:110℃ DDP-lipiodol via intra-aryerial thermochemotherapy is an effective and safe treatment for the patient with advanced hepatic carcinoma. The advanstages of the method is more than the disadvantages.
出处 《农垦医学》 2009年第5期409-412,共4页 Journal of Nongken Medicine
关键词 化疗栓塞 肝癌 不良反应 生存率 Thermochemotherapy Hepatic carcinoma Acomplications Existent rate
  • 相关文献

参考文献4

二级参考文献37

  • 1张家兴,樊树峰,郑家平,叶强,汝复明,奚顺法,童乾纲,顾伟中.肝癌的介入性热化疗:最佳灌注温度的探讨[J].介入放射学杂志,2004,13(5):450-452. 被引量:33
  • 2张洪新,刘燕,魏娟,刘毅勇,曹玮,倪代会,李文献,韩瑞炀.间歇和连续热化疗对兔肝VX-2移植瘤模型的安全有效性探讨(英文)[J].中国临床康复,2005,9(2):233-235. 被引量:3
  • 3李山云,何斌,张孝中.肝动脉“夹心面包”栓塞治疗原发性肝癌[J].中华放射学杂志,1994,28(4):268-269. 被引量:16
  • 4陆继珍.人体肝细胞肝癌血供的观察[J].肿瘤,1986,6:83-83.
  • 5[4]Chou F I,Fang K C,Chang C,et al.Lipiodol uptake and retention by human hepatoma cells[J].Nuc Med Biol,1995,22(3):379 ~ 386.
  • 6[8]Wang S J,Lin W Y,Chen M N,et al.Biodistribution of rhenium- 188 lipiodol infused via the hepatic artery of rats with hepatic tumors [J].Europ Nucr Med,1996,23:13 ~ 17.
  • 7[9]Madsen M T,Park C H,Takur M L.Dosimetry of iodine - 131ethiodol in the treatment of hepatoma [J].J Nucl Med,1988,29:1038 ~ 1044.
  • 8杜进,金小海,陈大明,等.125I-碘化油的研制[J].同位素,1995,8(2):71-75.
  • 9[11]Wang S J,Lin W Y,Chen M N,et al.Preparation and biodistribution of yttrium - 90 lipiodol in rats following hepatic arterial injection[J].Eur J Nucl Med,1995,22:233 ~ 236.
  • 10[12]Wang S J,Lin W Y,Chen M N,et al.Radiolabeling of lipiodol with generator - produced 188 Re for hepatic tumor therap[J].Applied Radiation and Isotopes,1996,47:267 ~ 271.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部